Summary. 
Introduction
The abortion-inducing property of the antiprogestagens RU-38486 and ZK-98734 is believed to be due to an inhibition of receptor-mediated progesterone action on the uterus (Philibert et ai, 1982;  Healy et ai, 1983; J. M. R. Pongubala, personal communication). Attempts to elucidate action of these antiprogestagens on corpus luteum function by measuring plasma progesterone concentration have yielded equivocal results. Asch & Rojas (1985) did not observe any difference in the plasma progesterone concentration in cyclic rhesus monkeys treated with RU-38486 during the luteal phase. In women, however, Kovacs etal.(\ 984) observed a dose-dependent decrease in plasma progesterone concentration and suggested a direct action of RU-38486 on luteal function. A similar decrease in plasma progesterone concentration in marmoset monkeys has been reported after treatment with ZK-98734 (S. D. Kholkute, personal communication) . In view of these findings and the reported high affinity of RU-38486 to ovarian progesterone and glucocorticoid receptors (Schreiber et al., 1983) , which have been suggested as having a role in ovarian morphology and hormone production (Schreiber & Hsueh, 1979; Schreiber et al., 1982; Erickson, 1983; Hsueh et ai, 1983) , we undertook an ultrastructural study to determine changes in the luteal cells of rats treated with a contraceptive dose of these antiprogestagens (W. Elger, unpublished data).
Materials and Methods
Colony bred adult Sprague-Dawley rats (200-250 g ) maintained at the institute in air-conditioned (22+ 1°C) quarters and under uniform husbandry conditions were used. The animals were kept in groups of 10 and were given a pellet diet (Hind Levers Ltd, Bombay) and tap water ad libitum. Females were caged overnight with coeval males of 'Reprint requests to Dr V. P. Kamboj. proven fertility (1 male:5 females) and were examined for the presence of spermatozoa in their vaginal smears on the following morning. The day of finding spermatozoa in the smear was taken as Day 1 of pregnancy.
In pilot studies, corpora lutea of rats treated with a contraceptive dose of RU-38486 (3 mg/day, s.c.) dissolved in castor oil:benzyl benzoate (4:1, v/v) on Days 5-7 post coitum and autopsied on Day 9 showed ultrastructural changes characteristic of luteolysis. To rule out involvement of the uterine luteolytic factor in the absence of viable implantation sites in treated animals (W. Elger, unpublished), a group of mated rats was bilaterally hysterectomized on Day 2 post coitum, a procedure which is known to maintain luteal function for almost the duration of normal gestation (Silbiger & Rothchild, 1963 (Mollenhauer, 1964) in Beem capsules and kept in a moisture-free oven at 60°C for 18-20 h to polymerize. The blocks were carefully trimmed and initially 1 urn thick sections were cut on an LKB Ultratome 8800 and stained with 1 % aqueous toluidine blue in 1 % sodium borate for localization ofrecent corpora lutea (Bruce et al., 1984) for ultrathin sectioning. The ultrathin sections (40-60 nm) were individually collected on clean 400 mesh grids, stained for 30 min with 1% uranyl acetate (Watson, 1958) and 5-10 min with lead citrate in a C02-free atmosphere (Reynolds, 1963) sham-operated and hysterectomized animals. There was, however, no effect of hysterectomy on ovarian weight (Table 1 (Fig. 2a) . The picture on Day 12 post coitum was virtually similar except that there was a marked increase in the amount and complexity of the smooth endoplasmic reticulum as well as the size of mitochondria. The matrix of some of the mitochondria contained small osmiophilic granules (Fig. 2b) .
In comparison, the corpora lutea of rats treated with the contraceptive dose of RU-38486 or ZK-98734 showed changes characteristic of luteolysis (Adams & Hertig, 1969; Koering & Kirton, 1973; Balboni, 1976 Fig. 2b, x 44 000 ). Fig. 3 , except that the cytoplasmic vacuolization was limited to distention of the vesicles of endoplasmic reticulum while still retaining their identity (arrow). (Figs 3a, b) . In rats autopsied on Day 12 there was an extensive hyalinization (Parrott et ai, 1986) of the corpora lutea (Fig. lc) . Ultrastructurally such corpora lutea contained only occasional luteal cells with a heterochromatic nucleus surrounded by a little cytoplasm. The degenerative changes induced by ZK-98734 were similar except that on Day 9 distended rough endoplasmic reticulum still retained its lamellated disposition and vacuolization of the cytoplasm was not as extensive as seen after RU-38486 treatment. Some mitochondria with myelinated figures were also observed (Figs 4a, b, c) . On Day 12, there was a comparatively little hyalinization of the corpora lutea of rats treated with the contraceptive dose of this compound (Fig. Id) . However, in rats treated with double the contraceptive dose of ZK-98734, the luteal cell cytoplasm lost its integrity because of degeneration of subcellular organdíes and the appearance of multivesicular bodies and electron-dense granules (Figs 5a, b Koering & Kirton, 1973; Balboni, 1976 Hertig, 1969) and near parturition (Balboni, 1976) or in rabbits after treatment with an abortifacient dose of prostaglandin F-2a (Koering & Kirton, 1973) . While a similar decrease in peripheral plasma progesterone concentration has been observed in women (Kovacs et al., 1984) (Enders, 1973; Long, 1973) . At Day 12 post coitum, some of the mitochondria contain small osmiophilic granules. Similar dark granules have been observed in normal mitochondria of luteal (Adams & Hertig, 1969) as well as non-luteal tissues (Haggis, 1966) . The exact composition or function of these granules is, however, not known.
The luteolytic effect of these antiprogestagens appears to be due to their direct action on the corpora lutea, since ovarian granulosa cells of rats, like those of other mammals, are known to contain receptors for progesterone and glucocorticoids (Louvet et al., 1977; Schreiber & Hsueh, 1979; Schreiber et al., 1982) and one of these compounds has been shown to bind to these receptors with very high affinity (Schreiber et al., 1983) . The present findings also confirm the regulatory role of receptor-mediated action of progesterone and glucocorticoids on ovarian progesterone production as has been demonstrated earlier by a number of studies (Erickson, 1983; Hsueh et ai, 1983) .
The luteolytic action of these agents does not appear to be mediated via production of the uterine luteolytic factor, PGF-2a (Pharris & Wyngarden, 1969) , in the absence of any viable implantation sites in the uteri of treated rats, since in the present studies almost similar degenerative changes in the corpora lutea and a decrease in peripheral plasma progesterone concentration were observed in treated rats hysterectomized on Day 2 of pregnancy, thereby eliminating the source of luteolysin, which normally extends the functional life of corpora lutea to almost the length of gestation (Silbiger & Rothchild, 1963) . It is, however, not known whether these agents have any effect on secretion of pituitary LH and prolactin or responsiveness of the ovaries to these luteotrophins, which are required for the first 12 days of pregnancy for sustained progesterone release from the corpora lutea, after which the placenta is known to secrete the luteotrophic complex (Lamprecht et ai, 1969; Hilliard, 1973) .
Previous studies have demonstrated a decrease in size of the corpora lutea undergoing regression (Blatchley & Donovan, 1969; Pharris, 1970) . In the present study, treatment with antiprogestagens produced a significant increase in the overall weight of the ovaries. Although we did not measure size or weight of the individual corpora lutea, the observed increase in weight of the ovaries does not appear to be due to functional corpora lutea which appeared pale and lacked the prominence and lustre characteristic of mid-gestation.
Since these compounds are being clinically evaluated for early abortifacient and mensesregulating activity when ovarian support is essential in almost all mammals, including primates (Csapo & Pulkkinen, 1978) , it is inferred that these agents might induce these effects via suppression of ovarian function in addition to their antagonism of receptor-mediated progesterone action on the uterus.
